Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics
Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms
About this trial
This is an interventional treatment trial for Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms focused on measuring Stroke, HES, Coagulation, Kinetics, Hemorehology
Eligibility Criteria
Inclusion Criteria: Age 18 - 70 yrs Clinical diagnosis of ischemic stroke No marked spontaneous improvement of symptoms before randomization Written informed consent from nearest relative. - Exclusion Criteria: Pregnancy Allergy to HES Severe impairment of consciousness Previous stroke with persistent ipsilateral deficits. Seizure at stroke onset. Intracranial neoplasm or AV malformation. Cardiac insufficiency or pulmonary edema Myocardial infarction during the previous 3 months or unstable angina. Severe dehydration Coagulation disorders. Uncontrolled Hypertension. Laboratory findings reflecting severe anemia, renal insufficiency, thrombocytopenia or hepatic insufficiency. Participation in another clinical trial within the previous 2 months or concurrent treatment with any other experimental drug. SECONDARY EXCLUSION CRITERIA. Cerebral CT at enrolment showing intracranial hemorrhage of any degree-